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Calcium channel β subunits (CaVβs) are essential cyto-
plasmic components of voltage-gated calcium channels
(VGCCs) affecting their gating and targeting. CaVβs bind
with high affinity to the cytoplasmic loop between trans-
membrane segments I and II of the α1 subunit (loop-I-II).
To identify new proteins that modulate VGCCs by interac-
tion with CaVβs we performed a yeast two-hybrid screen
using CaVβ2a as bait. Screening of a human fetal brain
cDNA library identified a C-terminal fragment of RIM1α
(Rab3-interacting molecule) which contains a highly con-
served C2B domain as potential interaction partner. To
proof the interaction between RIM and CaVβs we devel-
oped a protein targeting assay in tsA-201 cells heterolo-
gously expressing the loop-I-II of CaV1.3 channels with
diverse CaVβ subunits. The CaV1.3-loop-I-II was trans-
ported to the plasma membrane and co-targeted all CaVβ
subunits indicating that the CaV1.3-loop-I-II and the CaVβ
subunits formed a functional complex. The C-terminal
fragment of RIM1α or the full-length form of RIM2β
exhibited a cytoplasmic distribution but when co-
expressed with CaVβs in presence of the CaV1.3-loop-I-II
both were co-localized at the plasma membrane. Using
qualitative RT-PCR analysis we detected various RIM iso-
forms in the total organ of Corti and RIM2α in cochlea
inner hair cells (IHCs) at an early developmental stage,
before the onset of hearing. As RIM is a presynaptic active
zone protein involved in Ca2+-induced neurotransmitter
release, we asked the question whether the association of
RIM with CaV1.3 could account for the slow CaV1.3 cur-
rent inactivation seen in IHCs. In whole-cell patch-clamp
analysis of tsA-201 cells using 15 mM Ca2+ as charge car-
rier the C2B domain containing fragments of RIM1α and
RIM2α caused a significant depolarizing shift of the acti-
vation-curve of CaV1.3 (7–12 mV) and slowed the inacti-
vation of both Ca2+ and Ba2+ currents (p < 0.05) albeit to
a lesser extent as found in native IHCs. To investigate if a
slowly inactivating CaV1.3 spliceform (1b) could contrib-
ute to this effect we examined its expression with RT-PCR
analysis. However, we did not detect CaV1.3(1b) tran-
scripts in the total organ of Corti at the same developmen-
tal stage as we found RIM. Taken together these data
showed that indeed RIM modulated CaV1.3 Ca2+ chan-
nels. However, we assume that a mixture of diverse pro-
teins and/or CaV1.3 splice variants probably accounts for
the slow current inactivation of these channels in native
IHCs.
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